369 related articles for article (PubMed ID: 3882736)
1. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
2. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
3. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
[TBL] [Abstract][Full Text] [Related]
4. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
5. The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.
Fink RI; Revers RR; Kolterman OG; Olefsky JM
Diabetes; 1985 Mar; 34(3):275-80. PubMed ID: 3882495
[TBL] [Abstract][Full Text] [Related]
6. Starvation enhances the ability of insulin to inhibit its own secretion.
Brodows RG
Metabolism; 1985 Jan; 34(1):53-7. PubMed ID: 3880857
[TBL] [Abstract][Full Text] [Related]
7. Feedback inhibition of insulin secretion is altered in cirrhosis.
Cavallo-Perin P; Bruno A; Nuccio P; Goria M; Pagano G; Lenti G
J Clin Endocrinol Metab; 1986 Oct; 63(4):1023-7. PubMed ID: 3528209
[TBL] [Abstract][Full Text] [Related]
8. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
[TBL] [Abstract][Full Text] [Related]
9. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
11. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
Osei K
Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
[TBL] [Abstract][Full Text] [Related]
12. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
Lewis GF; Carpentier A; Vranic M; Giacca A
Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.
Ratheiser K; Reitgruber W; Komjati M; Bratusch-Marrain P; Vierhapper H; Waldhäusl WK
Acta Diabetol Lat; 1990; 27(3):197-213. PubMed ID: 2075783
[TBL] [Abstract][Full Text] [Related]
15. Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent.
Giugliano D; Cozzolino D; Salvatore T; Torella R; D'Onofrio F
Diabetes; 1988 Sep; 37(9):1265-70. PubMed ID: 2970411
[TBL] [Abstract][Full Text] [Related]
16. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K
J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
[TBL] [Abstract][Full Text] [Related]
17. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
18. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia.
DeFronzo RA; Binder C; Wahren J; Felig P; Ferrannini E; Faber OK
Acta Endocrinol (Copenh); 1981 Sep; 98(1):81-6. PubMed ID: 7025544
[TBL] [Abstract][Full Text] [Related]
20. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.
Gulli G; Ferrannini E; Stern M; Haffner S; DeFronzo RA
Diabetes; 1992 Dec; 41(12):1575-86. PubMed ID: 1446799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
